NPI: 1710939863 · FRESNO, CA 93727 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 42,992 | $1.36M |
| 2019 | 37,575 | $924K |
| 2020 | 27,962 | $701K |
| 2021 | 25,611 | $820K |
| 2022 | 26,725 | $1.00M |
| 2023 | 28,402 | $1.06M |
| 2024 | 20,328 | $913K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 102,295 | 8,694 | $6.48M |
| 90945 | 2,502 | 97 | $127K | |
| A4657 | Syringe, with or without needle, each | 22,630 | 4,036 | $87K |
| 0250 | 5,782 | 378 | $31K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,652 | 2,508 | $29K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 193 | 103 | $18K |
| J1756 | Injection, iron sucrose, 1 mg | 10,583 | 3,024 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,440 | 966 | $991.76 |
| J1270 | Injection, doxercalciferol, 1 mcg | 21,511 | 1,809 | $690.25 |
| 90940 | 700 | 684 | $156.37 | |
| 90747 | 30 | 30 | $145.21 | |
| 83970 | 1,293 | 1,096 | $113.00 | |
| 90674 | 266 | 262 | $69.00 | |
| 90662 | 70 | 63 | $58.80 | |
| 82728 | 878 | 752 | $22.97 | |
| 83540 | 874 | 751 | $10.88 | |
| 85041 | 1,574 | 1,287 | $8.66 | |
| 85048 | 1,507 | 1,222 | $7.33 | |
| 83550 | 595 | 479 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 465 | 339 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 382 | 367 | $0.00 |
| 82746 | 133 | 110 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 37 | 35 | $0.00 |
| 82607 | 131 | 108 | $0.00 | |
| 90732 | 38 | 36 | $0.00 | |
| G0010 | Administration of hepatitis b vaccine | 18 | 18 | $0.00 |
| 85045 | 1,628 | 930 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 3,358 | 313 | $0.00 |
| 90661 | 30 | 30 | $0.00 |